Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedFeb 28, 2018Tretinoin USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0530-2018Class IITerminatedFeb 28, 2018Tramadol HCl USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0529-2018Class IITerminatedFeb 28, 2018Testosterone USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0528-2018Class IITerminatedFeb 28, 2018Testosterone Enanthate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0527-2018Class IITerminatedFeb 28, 2018Testosterone Cypionate USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0526-2018Class IITerminatedFeb 28, 2018TestosteroneCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0525-2018Class IITerminatedFeb 28, 2018Tadalafil USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0524-2018Class IITerminatedFeb 28, 2018Tacrolimus USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0523-2018Class IITerminatedFeb 28, 2018Sumatriptan USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0522-2018Class IITerminatedFeb 28, 2018Sumatriptan Succinate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0521-2018Class IITerminatedFeb 28, 2018Stanozolol USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0520-2018Class IITerminatedFeb 28, 2018Sildenafil Citrate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0519-2018Class IITerminatedFeb 28, 2018Progesterone USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0518-2018Class IITerminatedFeb 28, 2018Prilocaine HCl USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0517-2018Class IITerminatedFeb 28, 2018Phentolamine Mesylate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0516-2018Class IITerminatedFeb 28, 2018Pentoxifylline USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0515-2018Class IITerminatedFeb 28, 2018Oxandrolone USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0514-2018Class IITerminatedFeb 28, 2018Nifedipine USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0513-2018Class IITerminatedFeb 28, 2018Nandrolone Decanoate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0512-2018Class IITerminatedFeb 28, 2018Naltrexone HCl USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0511-2018Class IITerminatedFeb 28, 2018Medroxyprogesterone Acetate USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0510-2018Class IITerminatedFeb 28, 2018Liothyronine Sodium USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0509-2018Class IITerminatedFeb 28, 2018Lincomycin HCl USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0508-2018Class IITerminatedFeb 28, 2018Lidocaine USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0507-2018Class IITerminatedFeb 28, 2018Lidocaine HCl USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0506-2018Class IITerminatedFeb 28, 2018Levothyroxine Sodium USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0505-2018Class IITerminatedFeb 28, 2018Levofloxacin Hemihydrate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0504-2018Class IITerminatedFeb 28, 2018Levocetirizine Dihydrochloride for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0503-2018Class IITerminatedFeb 28, 2018Levetiracetam USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0502-2018Class IITerminatedFeb 28, 2018Leucovorin Calcium USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0501-2018Class IITerminatedFeb 28, 2018Ketoprofen USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0500-2018Class IITerminatedFeb 28, 2018Ketoconazole USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0499-2018Class IITerminatedFeb 28, 2018Ketamine HCl USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0498-2018Class IITerminatedFeb 28, 2018Itraconazole USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0497-2018Class IITerminatedFeb 28, 2018Imiquimod USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0496-2018Class IITerminatedFeb 28, 2018Hydroxyprogesterone Caproate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0495-2018Class IITerminatedFeb 28, 2018Gabapentin USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0494-2018Class IITerminatedFeb 28, 2018Flurbiprofen USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0493-2018Class IITerminatedFeb 28, 2018Fluconazole USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0492-2018Class IITerminatedFeb 28, 2018Estrone USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0491-2018